4.6 Article

Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma

Related references

Note: Only part of the references are listed.
Review Biology

Overexpression of E-Cadherin Is a Favorable Prognostic Biomarker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Alejandro I. Lorenzo-Pouso et al.

Summary: Oral squamous cell carcinoma (OSCC) has a low survival rate and novel prognostic biomarkers are needed. Our study found that low expression of the protein E-cadherin is associated with poor prognosis in OSCC patients. Assessing E-cadherin during routine histopathology diagnoses could be a promising prognostic tool.

BIOLOGY-BASEL (2023)

Article Medicine, Research & Experimental

Altered expression of junctional proteins as a potential biomarker in oral precancerous and cancerous patients

Puja Upadhaya et al.

Summary: This study found a decrease in the expression of cell-cell junctional proteins E-cadherin and ZO-1 in oral precancerous and cancerous patients, which were associated with TNM stages. Patients with high expression of these proteins had longer survival times. The disruption of junctional complex and alteration of junctional proteins expression in oral cancer could be a potential therapeutic target.

TISSUE BARRIERS (2022)

Article Multidisciplinary Sciences

Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma

Soundara Viveka Thangaraj et al.

Summary: Oral Tongue Squamous Cell Carcinoma (OTSCC) is a distinct sub-group of head and neck cancers characterized by its aggressive nature and high incidence of recurrence and metastasis. Transcriptome analysis of OTSCC patients identified key genes and deregulated pathways, leading to the validation of a panel of valuable prognostic markers that can be clinically useful in identifying poor prognosis and occult node metastasis in OTSCC patients. Up-regulation of certain genes was associated with treatment failure in early stages, while other genes were significantly correlated with occult node positivity, indicating their potential as indicators of poor prognosis.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Immunologic Cold Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis

Julika Ribbat-Idel et al.

Summary: The study identified significant differences in survival rates among HNSCC patients based on their tumor immune cell patterns, with immunologic hot and excluded patients showing better overall survival. Categorizing HNSCC as immunologic hot, cold, or excluded using a plain histological approach may serve as a potential prognostic tool.

FRONTIERS IN MEDICINE (2021)

Article Oncology

Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence

Kenya Kobayashi et al.

Summary: TP53 mutations accumulation is common in recurrent head and neck squamous cell carcinoma, especially in oral cancer. The TP53 status of recurrent tumors is associated with post-recurrence survival, while the status of initial tumors is not. Full-coverage TP53 deep sequencing of recurrent tumors can help predict post-recurrence prognosis.

ORAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Oral and ocular late effects in head and neck cancer patients treated with radiotherapy

Kristine Loken Westgaard et al.

Summary: A study found that head and neck cancer patients treated with IMRT had more issues with dry mouth and dry eye compared to controls.

SCIENTIFIC REPORTS (2021)

Article Oncology

A Wnt-mediated phenotype switch along the epithelial-mesenchymal axis defines resistance and invasion downstream of ionising radiation in oral squamous cell carcinoma

Fatemeh Zolghadr et al.

Summary: This study demonstrates a hybrid epithelial-mesenchymal state in oral squamous cell carcinoma cells and tumour samples, with a key role identified for E-cadherin levels in stratifying cells to compartments with varying levels of radiation response. This response to radiation involves the generation of a new cell population with low E-cadherin expression and Vimentin positivity, showing enhanced capacity for radiation resistance and invasion. Transcription analysis highlights the Wnt signaling pathway's role in generating this cell population, influencing radiation resistance and tumour cell invasion.

BRITISH JOURNAL OF CANCER (2021)

Review Cell Biology

Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis

Ewa Nowak et al.

Summary: Epithelial to mesenchymal transition (EMT) is a critical process in tumor progression that influences metastasis, characterized by loss of cell adhesion and polarity, and enhanced cell motility. Epigenetic regulatory mechanisms play a significant role in the gene expression involved in EMT, impacting the development and progression of cancer.

CELLS (2021)

Article Oncology

Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion

Christian Watermann et al.

Summary: Recurrent tumors of head and neck squamous cell carcinoma have an immunosuppressive tumor immune microenvironment, particularly apparent after adjuvant chemoradiotherapy, which may substantially impact therapeutic response and prognosis.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway

Weihuang Yin et al.

Summary: Metformin exerts inhibitory effects on epithelial-mesenchymal transition in oral squamous cell carcinoma, potentially by suppressing the mTOR-associated HIF-1 alpha/PKM2/STAT3 signaling pathway to reverse EMT.

ONCOLOGY LETTERS (2021)

Review Medicine, Research & Experimental

Aberrant N-cadherin expression in cancer

Zhan-Qi Cao et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Oncology

Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities

Matthew R. Trendowski et al.

CLINICAL CANCER RESEARCH (2019)

Article Dentistry, Oral Surgery & Medicine

E-Cadherin gene expression in oral cancer: Clinical and prospective data

Sandra Lopez-Verdin et al.

MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2019)

Article Oncology

Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells

Teresa Bernadette Steinbichler et al.

ONCOTARGET (2018)

Review Medicine, Research & Experimental

Principles and approaches for reproducible scoring of tissue stains in research

David K. Meyerholz et al.

LABORATORY INVESTIGATION (2018)

Review Oncology

Immune Checkpoint Inhibition in Head and Neck Cancer

Martin David Forster et al.

FRONTIERS IN ONCOLOGY (2018)

Review Oncology

EMT in cancer

Thomas Brabletz et al.

NATURE REVIEWS CANCER (2018)

Article Biochemistry & Molecular Biology

Ecotropic viral integration site 1, a novel oncogene in prostate cancer

A. Queisser et al.

ONCOGENE (2017)

Review Biochemistry & Molecular Biology

EMT: 2016

M. Angela Nieto et al.

Article Oncology

E-cadherin expression and prognosis of oral cancer: a meta-analysis

Sheng-Lei Luo et al.

TUMOR BIOLOGY (2014)

Article Oncology

Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma

Chi-Chen Fan et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)

Review Medicine, Research & Experimental

The basics of epithelial-mesenchymal transition

Raghu Kalluri et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Dentistry, Oral Surgery & Medicine

The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation

Xinhong Wang et al.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2009)

Review Biochemistry & Molecular Biology

TGF-β and epithelial-to-mesenchymal transitions

J Zavadil et al.

ONCOGENE (2005)

Review Oncology

Cadherins and the tumour progression: is it all in a switch?

U Cavallaro et al.

CANCER LETTERS (2002)